All Clinical Trial Units (CTUs) at our member institutions are currently working at full speed to support research activities related to the COVID-19 outbreak. Some of the CTUs are involved in supporting international COVID-related research projects. All other research activities have been put on hold as far as possible.
Patient care comes first
CTUs may have to prioritise and reallocate resources in order to help researchers who are addressing this urgent situation. Furthermore, CTUs may have to redirect staff in order to support other activities in the hospitals, e.g. clinical care or administrative work.
Questions about ongoing research projects
CTU staff are available to answer questions about how to manage your ongoing projects. Additionally, Swissmedic and swissethics have prepared a joint document describing the most important recommendations for the treatment of patients in clinical trials of medicinal products. For the current version of the "Joint Guidance of Swissmedic and swissethics on the management of clinical trials with medicinal drug products in Switzerland during the COVID-19 pandemic" see www.swissmedic.ch.
Researchers interested in conducting studies on COVID-19 can contact their local CTU.